← Open Payments lookup

ZACHARY SHEPPARD: Open Payments

NPI 1205244753 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,835 in 72 payments from 17 companies in 2025. Trend: 2023 $209 · 2024 $1,784 · 2025 $1,835

Food & beverage: $1,835
CompanyPaymentsAmount
Novo Nordisk Inc20$628
Amgen Inc.11$375
AstraZeneca Pharmaceuticals LP10$214
GlaxoSmithKline, LLC.10$184
ABBVIE INC.3$68
Exact Sciences Corporation3$58
Kowa Pharmaceuticals America, Inc.3$49
Corcept Therapeutics2$40
Abbott Laboratories2$39
KYOWA KIRIN, INC.1$29

Products named: Wegovy, REPATHA, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, SHINGRIX, Rybelsus, Ozempic.

Industry payments across TX — which companies pay providers there.